These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28294892)

  • 21. [Comparative efficacy of combined therapy with preductal and amino acid composition in elderly patients with coronary heart disease and class II-III angina].
    Zaslavskaia RM; Kelimberdieva ES; Komissarova IA; Teĭblium MM; Goncharov LF; Goncharova ZF; Akhmetov KZh
    Ter Arkh; 1999; 71(11):58-61. PubMed ID: 10626340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myocardial metabolic manipulation: a new therapeutic approach in heart failure?
    O'Meara E; McMurray JJ
    Heart; 2005 Feb; 91(2):131-2. PubMed ID: 15657211
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of anti-ischemic and antianginal effect at trough plasma concentration and safety of trimetazidine MR 35 mg in patients with stable angina pectoris: a multicenter, double-blind, placebo-controlled study.
    Sellier P; Broustet JP
    Am J Cardiovasc Drugs; 2003; 3(5):361-9. PubMed ID: 14728070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical and hemodynamic efficacy of selective beta-blocker bisoprolol and cytoprotector trimetazidine in the treatment of chronic cardiac failure in patients with ischemic heart disease].
    Fedorova TA; Il'ina IuV; Sotnikova TI; Rybakova MK; Loshchits NV
    Ter Arkh; 2004; 76(3):62-8. PubMed ID: 15108463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of trimetazidine on quality of life in elderly patients with ischemic dilated cardiomyopathy.
    Marazzi G; Gebara O; Vitale C; Caminiti G; Wajngarten M; Volterrani M; Ramires JA; Rosano G; Fini M
    Adv Ther; 2009 Apr; 26(4):455-61. PubMed ID: 19396409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic therapy for ischemic heart disease: the rationale for inhibition of fatty acid oxidation.
    Stanley WC; Sabbah HN
    Heart Fail Rev; 2005 Dec; 10(4):275-9. PubMed ID: 16583175
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical-pharmacoeconomic aspects of trimetazidine modified release use in patients with ischemic heart disease undergoing coronary artery bypass grafting].
    Lopatin IuM; Dronova EP
    Kardiologiia; 2009; 49(2):15-21. PubMed ID: 19254211
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can metabolic manipulation reverse myocardial dysfunction?
    Cokkinos DV
    Eur Heart J; 2001 Dec; 22(23):2138-9. PubMed ID: 11913472
    [No Abstract]   [Full Text] [Related]  

  • 29. Trimetazidine administration minimizes myocardial damage and improves left ventricular function after percutaneous coronary intervention.
    Labrou A; Giannoglou G; Zioutas D; Fragakis N; Katsaris G; Louridas G
    Am J Cardiovasc Drugs; 2007; 7(2):143-50. PubMed ID: 17503885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trimetazidine on ischemic injury and reperfusion in coronary artery bypass grafting.
    Martins GF; Siqueira Filho AG; Santos JB; Assunção CR; Bottino F; Carvalho KG; Valência A
    Arq Bras Cardiol; 2011 Sep; 97(3):209-16. PubMed ID: 21808851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Trimetazidine addition to antianginal therapy: effects on efficacy and quality of life in patients with stable angina treated outpatiently].
    Ter Arkh; 2012; 84(4):38-41. PubMed ID: 22774489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antiischemic efficacy of trimetazidine in patients with ischemic heart disease, stable angina pectoris and disturbances of carbohydrate metabolism].
    Fedotkina IuA; Panchenko EP
    Kardiologiia; 2002; 42(2):28-33. PubMed ID: 12494204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of trimetazidine plus sildenafil to chronic nitrates in the control of myocardial ischemia during sexual activity in patients with coronary artery disease.
    Rosano GM; Marazzi G; Patrizi R; Cerquetani E; Vitale C; Volterrani M; Fini M; Mercuro G
    Am J Cardiol; 2005 Feb; 95(3):327-31. PubMed ID: 15670539
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trimetazidine in Angina Combination Therapy--the TACT study: trimetazidine versus conventional treatment in patients with stable angina pectoris in a randomized, placebo-controlled, multicenter study.
    Chazov EI; Lepakchin VK; Zharova EA; Fitilev SB; Levin AM; Rumiantzeva EG; Fitileva TB
    Am J Ther; 2005; 12(1):35-42. PubMed ID: 15662290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trimetazidine in Practice: Review of the Clinical and Experimental Evidence.
    Dézsi CA
    Am J Ther; 2016; 23(3):e871-9. PubMed ID: 25756467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trimetazidine in the myocardial cell mechanisms of cytoprotection.
    Labrid C
    Rom J Intern Med; 1998; 36(3-4):137-44. PubMed ID: 10822510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic treatment of myocardial ischaemia.
    Ferrari R
    Eur Heart J; 1999 Aug; 20(16):1144-5. PubMed ID: 10448019
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treating ischemic heart disease by pharmacologically improving cardiac energy metabolism].
    Lopaschuk GD
    Presse Med; 1998 Dec; 27(39):2100-4. PubMed ID: 9893703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Myocardial cytoprotection with trimetazidine in patients with ischemic heart disease during surgical stress].
    Afanas'eva IV; Goncharova LL; Miroshnichenko AG; Petrash VV; Pokrovskaia LA
    Vestn Khir Im I I Grek; 1999; 158(5):34-7. PubMed ID: 10645577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current Clinical Evidence of Trimetazidine in the Management of Heart Disease in Patients with Diabetes.
    Mahajan S; Mahajan AU
    J Assoc Physicians India; 2020 Nov; 68(11):46-50. PubMed ID: 33187037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.